The management of Goldshield Pharmaceuticals’s over-the-counter brands — Kamillosan, Infaderm and Infadrops — has passed to Ceuta Healthcare. Goldshield says that all current ordering and invoicing procedures will remain unchanged, but the brand management and development will be handled by Ceuta.